Press releases
These press releases are intended for business journalists and analysts/investors
New VentureWise program on COPD and asthma
Read more - New VentureWise program on COPD and asthma Read more
A shot in the arm for a shot at gold
- GSK Australia supplies travel vaccines for Olympic Team
Bactroban (mupirocin) 2% Ointment supply
Read more - Bactroban (mupirocin) 2% Ointment supply Read more
Easier access to medicines for men with enlarged prostates following medicine reimbursement changes
- Changes trigger better access to the treatment of enlarged prostate
- GPs set to play a more prominent role in managing moderate to severe BPH.
Supply of Zovirax Ophthalmic Ointment (aciclovir 3%) resumes
Resumed supply of Zovirax Ophthalmic Ointment confirmed following a global supply shortage.
Read more - Supply of Zovirax Ophthalmic Ointment (aciclovir 3%) resumes Read more
Product Recall - Children's Panadol
We are recalling two batches of Children’s Panadol 5-12 Suspension Strawberry (200mL) and one batch of Children’s Panadol 5-12 Suspension Orange (200mL)
GSK Australia Reports 2015 results to ASIC
GlaxoSmithKline (GSK) Australia has reported its 2015 results to the Australian Securities and Investment Commission (ASIC) for its pharmaceuticals and vaccines business, as well as GSK Consumer Healthcare (a joint venture with Novartis) and ViiV (a joint venture with Pfizer and Shionogi focused on HIV).
Read more - GSK Australia Reports 2015 results to ASIC Read more
GSK discloses payments to Australian healthcare professionals in 2015
In 2015, GSK Australia made payments totalling $3.6 million to healthcare professionals (HCPs) and health-related organisations (HCOs) for grants, sponsorships and consultancy fees related to chairing and speaking at meetings, assistance with training and participation in advisory boards.
Read more - GSK discloses payments to Australian healthcare professionals in 2015 Read more
Supply of Bactroban products
GSK advises of a temporary disruption to the supply of Bactroban products